LMAT Q2 2023 Earnings — LeMaitre Vascular, Inc. Revenue & Financial Results | Market Cap Arena

LMATLeMaitre Vascular, Inc.

$3B

Q2 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$50M+19.0% YoY

Gross Profit

$32M64.0% margin

Operating Income

$9M18.9% margin

Net Income

$8M16.2% margin

EPS (Diluted)

$0.36

QoQ Revenue Growth

+6.5%

Cash Flow

Operating Cash Flow

$12M

Free Cash Flow

$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$326M

Total Liabilities

$43M

Stockholders' Equity

$284M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$50M	$42M	+19.0%
Gross Profit	$32M	$28M	+15.4%
Operating Income	$9M	$6M	+63.4%
Net Income	$8M	$4M	+130.4%

Geographic Segments

Americas

$34M67%

EMEA

$14M27%

Asia Pacific

$3M6%